CANNPRISMA receives Portuguese medical cannabis licence
The authorisation followed an on-site inspection by both PSP and INFARMED.
Read moreStephanie is a journalist for Business of Cannabis, writing about science, research, policy and industry developments in cannabis, CBD and psychedelics. In 2013 Stephanie gained her BA in English and Media, focusing on journalism and propaganda, where her magazine 'Game Theory' focused on developments and disruptors over the coming decade including cannabis, psychedelics, blockchain/crypto and free speech. In 2015 Stephanie received her National Council for the Training of Journalists (NCTJ) diploma whilst working as a reporter in North Wales. Stephanie has a specialism in Medical Cannabis: The Health Effects of THC and CBD through the University of Colorado, and a certificate from the Medical Cannabis Clinicians Society on "Medical Cannabis Explained".
The authorisation followed an on-site inspection by both PSP and INFARMED.
Read moreThe compound was selected based on a wide-ranging screen of derivatives of CBD and CBG made by cannabis pioneer Professor...
Read moreCuraleaf aims to improve access and affordability for UK patients with its new products.Â
Read moreThe physical store complements Voyager's existing online sales and growing number of trade accounts.
Read moreUK SPAC has submitted a first draft of the prospectus to the FCA and has made an application in respect of a Standard Listing.
Read moreUK company Quantum Farma is working with FarmaUSA to launch two new cannabis treatments in the Latin American market.
Read moreThe products are currently being used in Israel for oncology patients for cancer pain, loss of appetite and other side...
Read moreThe first-of-its-kind report from New Frontier Data says that years of prohibition and an international illicit market have presented distinct...
Read morePeakbirch Logic has acquired Stul Ltd and its ‘Hot Box Herb’ brand in a move that will accelerate its goal...
Read moreMGC Pharma is hoping to bring more surprises to the market in the next few years.
Read more© 2024 Prohibition Holdings Ltd. All Rights Reserved.
© 2023 Prohibition Holdings Ltd. All Rights Reserved.